Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lenka Stefancikova

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Oncology|February 4, 2010
Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphomaLenka Stefancikova, Mojmir Moulis, Pavel Fabian, et al.
Cellular Signalling|January 17, 2012
The BRCA1 alternative splicing variant Δ14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cellsJan Sevcik, Martin Falk, Petra Kleiblova, et al.
International Journal of Oncology|August 30, 2011
Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphomaLenka Stefancikova, Mojmir Moulis, Pavel Fabian, et al.
Nanotechnology|November 30, 2019
Uptake and excretion dynamics of gold nanoparticles in cancer cells and fibroblastsVladimir Ivošev, Gloria Jiménez Sánchez, Lenka Stefancikova, et al.
International Journal of Nanomedicine|May 5, 2016
Improving proton therapy by metal-containing nanoparticles: nanoscale insightsThomas Schlathölter, Pierre Eustache, Erika Porcel, et al.
Cellular Signalling|February 19, 2013
Expression of human BRCA1Δ17-19 alternative splicing variant with a truncated BRCT domain in MCF-7 cells results in impaired assembly of DNA repair complexes and aberrant DNA damage responseJan Sevcik, Martin Falk, Libor Macurek, et al.
International Journal of Molecular Sciences|September 22, 2019
Fluorescent Radiosensitizing Gold NanoparticlesGloria Jiménez Sánchez, Pauline Maury, Lenka Stefancikova, et al.
Cell Reports|July 3, 2026
A non-catalytic function for RAD18 in sustaining glioblastoma proliferationNour Benbahouche, Antoine Aze, Aurore Siegfried, et al.
Cancer Research|August 24, 2012
Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical featuresAlba Navarro, Guillem Clot, Cristina Royo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Oncology|February 4, 2010
Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphomaLenka Stefancikova, Mojmir Moulis, Pavel Fabian, et al.
Cellular Signalling|January 17, 2012
The BRCA1 alternative splicing variant Δ14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cellsJan Sevcik, Martin Falk, Petra Kleiblova, et al.
International Journal of Oncology|August 30, 2011
Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphomaLenka Stefancikova, Mojmir Moulis, Pavel Fabian, et al.
Nanotechnology|November 30, 2019
Uptake and excretion dynamics of gold nanoparticles in cancer cells and fibroblastsVladimir Ivošev, Gloria Jiménez Sánchez, Lenka Stefancikova, et al.
International Journal of Nanomedicine|May 5, 2016
Improving proton therapy by metal-containing nanoparticles: nanoscale insightsThomas Schlathölter, Pierre Eustache, Erika Porcel, et al.
Cellular Signalling|February 19, 2013
Expression of human BRCA1Δ17-19 alternative splicing variant with a truncated BRCT domain in MCF-7 cells results in impaired assembly of DNA repair complexes and aberrant DNA damage responseJan Sevcik, Martin Falk, Libor Macurek, et al.
International Journal of Molecular Sciences|September 22, 2019
Fluorescent Radiosensitizing Gold NanoparticlesGloria Jiménez Sánchez, Pauline Maury, Lenka Stefancikova, et al.
Cell Reports|July 3, 2026
A non-catalytic function for RAD18 in sustaining glioblastoma proliferationNour Benbahouche, Antoine Aze, Aurore Siegfried, et al.
Cancer Research|August 24, 2012
Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical featuresAlba Navarro, Guillem Clot, Cristina Royo, et al.
Pageof 1